FEN 1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
L He, L Luo, H Zhu, H Yang, Y Zhang, H Wu… - Molecular …, 2017 - Wiley Online Library
Lung cancer is one of the leading causes of cancer mortality worldwide. The therapeutic
effect of chemotherapy is limited due to the resistance of cancer cells, which remains a …
effect of chemotherapy is limited due to the resistance of cancer cells, which remains a …
[引用][C] FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer
L He, L Luo, H Zhu, H Yang, Y Zhang, H Wu, H Sun… - Molecular …, 2017 - cir.nii.ac.jp
FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung
cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
FEN 1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
L He, L Luo, H Zhu, H Yang, Y Zhang, H Wu… - Molecular …, 2017 - search.proquest.com
Lung cancer is one of the leading causes of cancer mortality worldwide. The therapeutic
effect of chemotherapy is limited due to the resistance of cancer cells, which remains a …
effect of chemotherapy is limited due to the resistance of cancer cells, which remains a …
[PDF][PDF] FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer
L He, L Luo, H Zhu, H Yang, Y Zhang, H Wu, H Sun… - fitgene.com
Lung cancer is one of the leading causes of cancer mortality worldwide. The therapeutic
effect of chemotherapy is limited due to the resistance of cancer cells, which remains a …
effect of chemotherapy is limited due to the resistance of cancer cells, which remains a …
FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.
L He, L Luo, H Zhu, H Yang, Y Zhang, H Wu… - Molecular …, 2017 - europepmc.org
Lung cancer is one of the leading causes of cancer mortality worldwide. The therapeutic
effect of chemotherapy is limited due to the resistance of cancer cells, which remains a …
effect of chemotherapy is limited due to the resistance of cancer cells, which remains a …
[引用][C] FEN 1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
L He, L Luo, H Zhu, H Yang, Y Zhang, H Wu… - Molecular …, 2017 - Wiley Online Library
Figure 1E was mistakenly replaced by Fig. 1G of He et al.(2016) during the final assembly of
the figures for review. The corrected figure is provided below. The authors apologize for the …
the figures for review. The corrected figure is provided below. The authors apologize for the …
FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer
L He, L Luo, H Zhu, H Yang, Y Zhang… - Molecular …, 2017 - pubmed.ncbi.nlm.nih.gov
[HTML][HTML] FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
L He, L Luo, H Zhu, H Yang, Y Zhang, H Wu… - Molecular …, 2017 - ncbi.nlm.nih.gov
Lung cancer is one of the leading causes of cancer mortality worldwide. The therapeutic
effect of chemotherapy is limited due to the resistance of cancer cells, which remains a …
effect of chemotherapy is limited due to the resistance of cancer cells, which remains a …
FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer
L He, L Luo, H Zhu, H Yang, Y Zhang, H Wu, H Sun… - Survival - cyberleninka.org
FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell
lung cancer Page 1 CORRIGENDUM FEN1 promotes tumor progression and confers …
lung cancer Page 1 CORRIGENDUM FEN1 promotes tumor progression and confers …
FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
L He, L Luo, H Zhu, H Yang, Y Zhang, H Wu… - Molecular …, 2017 - ncbi.nlm.nih.gov
FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung
cancer - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
cancer - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …